SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001082554-20-000017
Filing Date
2020-10-28
Accepted
2020-10-28 06:12:23
Documents
72
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q uthr-20200930.htm   iXBRL 10-Q 2067812
2 EX-31.1 uthrex31109302020.htm EX-31.1 15481
3 EX-31.2 uthrex31209302020.htm EX-31.2 15481
4 EX-32.1 uthrex32109302020.htm EX-32.1 8872
5 EX-32.2 uthrex32209302020.htm EX-32.2 8900
  Complete submission text file 0001082554-20-000017.txt   8506479

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT uthr-20200930.xsd EX-101.SCH 51360
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT uthr-20200930_cal.xml EX-101.CAL 83190
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT uthr-20200930_def.xml EX-101.DEF 309115
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT uthr-20200930_lab.xml EX-101.LAB 674912
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT uthr-20200930_pre.xml EX-101.PRE 436936
11 EXTRACTED XBRL INSTANCE DOCUMENT uthr-20200930_htm.xml XML 1580584
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26301 | Film No.: 201266033
SIC: 2834 Pharmaceutical Preparations